共 20 条
Introducing a forced choice recognition trial to the Hopkins Verbal Learning Test - Revised
被引:35
|作者:
Abeare, Christopher A.
[1
]
Hurtubise, Jessica L.
[1
]
Cutler, Laura
[1
]
Sirianni, Christina
[2
]
Brantuo, Maame
[1
]
Makhzoum, Nadeen
[1
]
Erdodi, Laszlo A.
[1
]
机构:
[1] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada
[2] Univ Windsor, Sch Social Work, Windsor, ON, Canada
关键词:
Hopkins Verbal Learning Test;
forced choice recognition;
experimental malingering;
performance validity;
MALINGERED NEUROCOGNITIVE DYSFUNCTION;
PERFORMANCE VALIDITY TESTS;
TRAUMATIC BRAIN-INJURY;
INTELLIGENCE SCALE-4TH EDITION;
COMPLEX IDEATIONAL MATERIAL;
FINGER TAPPING TEST;
BOSTON NAMING TEST;
RAW SCORE CUTOFFS;
WORD MEMORY TEST;
RESPONSE BIAS;
D O I:
10.1080/13854046.2020.1779348
中图分类号:
B849 [应用心理学];
学科分类号:
040203 ;
摘要:
Objective This study was designed to replicate previous research on embedded validity indicators (EVIs) in the Hopkins Verbal Learning Test - Revised (HVLT-R) and introduce a new forced choice recognition trial (FCR). Method Undergraduate research volunteers were randomly assigned (M-Age= 21.7;M-Education= 14.5 years, 85% female) to either the control or experimental malingering condition, and were administered a brief battery of neuropsychological tests. Results Recognition memory based EVIs (both existing and newly introduced) effectively discriminated credible and non-credible response sets. An FCR <= 11 produced .59 sensitivity and perfect specificity to invalid responding. A Recognition Discrimination (RD) score <= 8 also produced a good combination of sensitivity (.35) and specificity (.96). The FCR trial made unique contributions to performance validity assessment above and beyond previously published EVIs. Conclusions RD achieved >=.90 specificity at higher cutoffs than previously reported. The newly introduced FCR trial has the potential to enhance the existing arsenal of EVIs within the HVLT-R. However, it must demonstrate its ability to differentiate genuine impairment from non-credible responding before it can be recommended for clinical use.
引用
收藏
页码:1442 / 1470
页数:29
相关论文